| A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump (NCT07152730) | Ferring Pharmaceuticals | 2025-09-12 |
| To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice (NCT07029451) | Ferring Pharmaceuticals | 2025-08-05 |
| Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis (NCT06668493) | Ferring Pharmaceuticals | 2025-06-12 |
| Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer (NCT06510374) | Ferring Pharmaceuticals | 2024-10-01 |
| Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings (NCT06561958) | Ferring Pharmaceuticals | 2024-08-27 |
| An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation. (NCT06511791) | Ferring Pharmaceuticals | 2024-07-15 |
| Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese Persons (NCT06515834) | Ferring Pharmaceuticals | 2024-07-01 |
| A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. (NCT06390111) | Ferring Pharmaceuticals | 2024-06-17 |
| An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation (NCT06466486) | Ferring Pharmaceuticals | 2024-06-14 |
| A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (NCT06173869) | Ferring Pharmaceuticals | 2024-03-29 |
| A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons (NCT06298032) | Ferring Pharmaceuticals | 2024-02-20 |
| ADSTILADRIN Early Utilization and Outcomes in the Real World Setting (NCT06026332) | Ferring Pharmaceuticals | 2023-09-15 |
| REBYOTA™ Prospective Registry (NCT05835219) | Ferring Pharmaceuticals | 2023-06-19 |
| A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects (NCT05924321) | Ferring Pharmaceuticals | 2023-05-25 |
| A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection (NCT05831189) | Ferring Pharmaceuticals | 2023-04-21 |
| Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC) (NCT05704244) | Ferring Pharmaceuticals | 2022-12-21 |
| Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation (NCT05571111) | Ferring Pharmaceuticals | 2022-10-04 |
| REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies) (NCT06545877) | Ferring Pharmaceuticals | 2022-09-16 |
| Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment (NCT04814940) | Ferring Pharmaceuticals | 2022-09-01 |
| Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice (NCT05499052) | Ferring Pharmaceuticals | 2022-08-28 |
| A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM) (NCT05403476) | Ferring Pharmaceuticals | 2022-08-16 |
| A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation (NCT05263388) | Ferring Pharmaceuticals | 2022-07-15 |
| Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (NCT04113382) | Ferring Pharmaceuticals | 2022-06-23 |
| Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women (NCT04773353) | Ferring Pharmaceuticals | 2021-12-03 |
| MEDAM (Menopur Retrospective Data prograM) (NCT04876300) | Ferring Pharmaceuticals | 2021-11-04 |
| A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women (NCT04902131) | Ferring Pharmaceuticals | 2021-11-02 |
| Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea (NCT04499495) | Ferring Pharmaceuticals | 2021-10-25 |
| NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden (NCT04740645) | Ferring Pharmaceuticals | 2021-07-13 |
| Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population (NCT04852120) | Ferring Pharmaceuticals | 2021-04-01 |
| General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation) (NCT04773314) | Ferring Pharmaceuticals | 2021-02-28 |
| Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta) (NCT04654039) | Ferring Pharmaceuticals | 2020-10-26 |
| Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice (NCT04503707) | Ferring Pharmaceuticals | 2020-06-17 |
| Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia) (NCT04329975) | Ferring Pharmaceuticals | 2020-05-19 |
| Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART) (NCT04163458) | Ferring Pharmaceuticals | 2019-10-25 |
| Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study) (NCT04340895) | Ferring Pharmaceuticals | 2019-10-14 |
| Cortiment® MMX Pharmacokinetic Study (NCT04080713) | Ferring Pharmaceuticals | 2019-09-16 |
| FIRMAGON® Intensive Drug Monitoring (NCT05181800) | Ferring Pharmaceuticals | 2019-08-20 |
| Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis (NCT03749109) | Ferring Pharmaceuticals | 2019-08-19 |
| A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US (NCT04125186) | Ferring Pharmaceuticals | 2019-07-22 |
| Rekovelle PK Trial in Chinese Women (NCT04150861) | Ferring Pharmaceuticals | 2019-06-23 |
| Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND) (NCT03809429) | Ferring Pharmaceuticals | 2019-04-29 |
| Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain (NCT03692403) | Ferring Pharmaceuticals | 2018-12-26 |
| Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) (NCT03738618) | Ferring Pharmaceuticals | 2018-10-29 |
| Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) (NCT03740737) | Ferring Pharmaceuticals | 2018-10-26 |
| Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE® (NCT03697031) | Ferring Pharmaceuticals | 2018-09-01 |
| Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures (NCT03565211) | Ferring Pharmaceuticals | 2018-07-26 |
| Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome (NCT03274973) | Ferring Pharmaceuticals | 2018-05-14 |
| A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. (NCT03564509) | Ferring Pharmaceuticals | 2018-05-14 |
| Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures (NCT03393780) | Ferring Pharmaceuticals | 2018-03-16 |
| To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis (NCT03412682) | Ferring Pharmaceuticals | 2018-03-02 |
| Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women (NCT03296527) | Ferring Pharmaceuticals | 2017-12-01 |